EUVIMEDEUVIMED entdecken
Crossref

Triple-Targeted Peptide–Photosensitizer–Drug Conjugate Enables NIR-II Imaging-Guided Multimodal Therapy Against Osteosarcoma

Xiaofan He iD, Xiao Liang, Jiaying Yu, Jie Rong, Jinzhong Hu, Chensen Xu, Zhuoer Cai, Jian Chen, Yinan Zhang, Xin Pu, Pengfei Sun, Hongshuai Wu und 1 weitere

ACS Nano · 2026

DOI: 10.1021/acsnano.6c01282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Xiaofan He und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China. Hauptthemen laut MEDLINE: Osteosarcoma, Photosensitizing Agents, Antineoplastic Agents, Bone Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: Wuxi Health and Family Planning Commission, Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaPhotosensitizing AgentsAntineoplastic AgentsBone NeoplasmsAnimalsHumansMiceCell Line, TumorInfrared RaysProdrugsOptical ImagingPhotochemotherapyMice, NudeOligopeptides

Stichwörter der Autor:innen

Hypoxia-Activated ProdrugMolecular DesignOsteosarcoma TherapyPhototheranosticsTheranostics

Substanzen

Photosensitizing AgentsAntineoplastic AgentsProdrugsarginyl-glycyl-aspartic acidOligopeptides

Autor:innen und Institutionen

  • School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China.
  • Wuxi Key Laboratory of Biomaterials for Clinical Application, Key Laboratory for Multidisciplinary Intersection of Radiotherapy and Immunology for Gastrointestinal Tumor, Department of Central Laboratory, Jiangyin Clini…
  • State Key Laboratory of Organic Electronics and Information Displays & Institute of Advanced Materials (IAM) Jiangsu Key Laboratory for Biosensors, Nanjing University of Posts & Telecommunications, Nanjing 210023, China.
  • Bozhou UK Biomedical Technology Co LTD., Bozhou 236800, China.
  • State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun 130012, China.

ORCID-Profile: Xiaofan He

Förderung

  • Wuxi Health and Family Planning Commission
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • Affiliated Hospital of Xuzhou Medical University

Zitieren

APA

He, X., Liang, X., Yu, J., Rong, J., Hu, J., Xu, C., Cai, Z., Chen, J., Zhang, Y., Pu, X., Sun, P., Wu, H., & Sun, B. (2026). Triple-Targeted Peptide–Photosensitizer–Drug Conjugate Enables NIR-II Imaging-Guided Multimodal Therapy Against Osteosarcoma. ACS Nano. https://doi.org/10.1021/acsnano.6c01282

Vancouver

He X, Liang X, Yu J, Rong J, Hu J, Xu C, et al. Triple-Targeted Peptide–Photosensitizer–Drug Conjugate Enables NIR-II Imaging-Guided Multimodal Therapy Against Osteosarcoma. ACS Nano. 2026. doi:10.1021/acsnano.6c01282

BibTeX
@article{He2026,
  author = {He, Xiaofan and Liang, Xiao and Yu, Jiaying and Rong, Jie and Hu, Jinzhong and Xu, Chensen and Cai, Zhuoer and Chen, Jian and Zhang, Yinan and Pu, Xin and Sun, Pengfei and Wu, Hongshuai and Sun, Baiwang},
  title = {Triple-Targeted Peptide–Photosensitizer–Drug Conjugate Enables NIR-II Imaging-Guided Multimodal Therapy Against Osteosarcoma},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.6c01282}
}
Kostenlos starten →